Fill-in the information below to submit your event.
Fill in the information below to download the Survey.
Fill in the information below to download the Product Catalog.
Fill in the information below to download the Investor Package.
Fill in the information below to register as a journalist.
Fill in the information below to download the Factsheet.
Fill in the information below to download the Product Catalog.
Fill in the information below to download the list of firms.
Fill in the information below to download the LP Package.
Fill in the information below to download the Factsheet.
Fill in the information below to download the Wealth Discovery Package.
Fill in the information below to download the IPEM Playbook – Navigating the Wealth Revolution.
Fill in the information below to download the Factsheet.
The general public did not know much about mRNA vaccines a few months ago; now biotech firms like Moderna, BioNTech or CureVac have almost become household brand-names! We spoke this month with Sander Slootweg, Founder and Managing Partner of Forbion – one of the leading biotech investors in Europe. He told us about the incredible breakthrough life sciences have made in the last decades, how the European biotech ecosystem is reaching new milestones and why LPs are increasingly interested in this space.
Enjoy this May IPEM rendez-vous!
Table of content
A special thank you to Sander Slootweg, Co-Founder & Managing Partner of Forbion, for sharing with us his thoughts!
And stay tuned for the next IPEM RDV!
Become part of the IPEM Community
Follow us
News
IPEM Cannes 2024 – The Daily Spin – January, 25th
The shifting role of LPs was the overarching theme for the morning session of Day 2, at the 10th edition of IPEM in Cannes. After a full day of yoga,…